Evaluating Duloxetine's Analgesic Effectiveness in Chronic Pelvic Pain

Trial Profile

Evaluating Duloxetine's Analgesic Effectiveness in Chronic Pelvic Pain

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 14 Apr 2017

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Pelvic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Apr 2017 Status changed from active, no longer recruiting to discontinued.
    • 02 Apr 2015 Planned End Date changed from 1 Nov 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.
    • 02 Apr 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top